| E-Y0001389 |
EP |
【坎地沙坦酯系統(tǒng)適 |
Candesartan cilexetil for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0001390 |
EP |
【醋酸環(huán)丙孕酮峰值 |
Cyproterone acetate for peak identification |
|
5 mg |
1264 |
28 |
| E-Y0001391 |
EP |
【甘油縮甲醛（訂貨以 |
Glycerol formal |
|
20 mg |
1264 |
28 |
| E-Y0001392 |
EP |
【奧氮平雜質A（訂貨 |
0lanzapine impurity A |
|
5 mg |
1264 |
28 |
| E-Y0001393 |
EP |
【鹽酸林可霉素系統(tǒng) |
Lincomycin hydrochloride for system suitability |
|
10 mg |
1484.59 |
42 |
| E-Y0001394 |
EP |
【夫西地酸峰值鑒別 |
Fusidic acid for peak identification |
|
5 mg |
1484.59 |
42 |
| E-Y0001395 |
EP |
【伏立康唑（訂貨以英 |
Voriconazole |
|
120 mg |
1264 |
28 |
| E-Y0001396 |
EP |
【伏立康唑雜質B（訂 |
Voriconazole impurity B |
|
10 mg |
1264 |
28 |
| E-Y0001397 |
EP |
【伏立康唑雜質E（訂 |
Voriconazole impurity E |
|
50 mg |
1264 |
28 |
| E-Y0001398 |
EP |
【伏立康唑雜質D（訂 |
Voriconazole impurity D |
|
10 mg |
1264 |
28 |
| E-Y0001399 |
EP |
【氟維司群（訂貨以英 |
Fulvestrant |
|
120 mg |
1264 |
28 |
| E-Y0001400 |
EP |
【氨己烯酸（訂貨以英 |
Vigabatrin |
|
10 mg |
1264 |
28 |
| E-Y0001401 |
EP |
【氨己烯酸雜質A（訂 |
Vigabatrin impurity A |
|
25 mg |
1484.59 |
42 |
| E-Y0001402 |
EP |
【氨己烯酸雜質B（訂 |
Vigabatrin impurity B |
|
20 mg |
1264 |
28 |
| E-Y0001403 |
EP |
【氨己烯酸雜質E（訂 |
Vigabatrin impurity E |
|
10 mg |
1264 |
28 |
粵公網安備 44010302000979號